SCHEMBL6424045

SCHEMBL6424045

O[C@@H]1CSSC[C@@H]1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19168030 1.00
SCHEMBL1628866 1.00
SCHEMBL17232123 1.00
SCHEMBL1628862 1.00
SCHEMBL561454 1.00
SCHEMBL19242845 0.75
SCHEMBL18266878 0.73
SCHEMBL16176584 0.73 PTPN1 (0.32)
SCHEMBL16176240 0.73 PTPN1 (0.32)
SCHEMBL16176245 0.73 PTPN1 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1023284-B1 ANTI-VIRAL PHARMACEUTICAL COMPOSITIONS CONTAINING SATURATED 1,2-DITHIAHETEROCYCLIC COMPOUNDS US GOV HEALTH & HUMAN SERV (US) 2005-11-23 EP claimed
US-6046228-A INCLUDE 1,2-DITHIANE AND 1,2 DITHIOLANE COMPOUNDS, THE RING SULFUR ATOMS MAY BE PRESENT IN THE SULFUR OXIDE OR SULFONE STATE, USEFUL FOR INHIBITING RETROVIRUS REPLICATION THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2000-04-04 US claimed
WO-1998001440-A9 ANTI-VIRAL PHARMACEUTICAL COMPOSITIONS CONTAINING SATURATED 1,2-DITHIAHETEROCYCLIC COMPOUNDS AND USES THEREOF 1998-07-16 WO claimed
US-11723857-B2 Covalent treatment with thiols of keratin-containing materials LIVING PROOF, INC. (US) 2023-08-15 US disclosed
US-10993903-B2 Covalent treatment with thiols of keratin-containing materials LIVING PROOF, INC. (US) 2021-05-04 US disclosed
US-10844038-B2 1,2-dithiolane compounds useful in neuroprotection, autoimmune and cancer diseases and conditions SABILA BIOSCIENCES LLC (US) 2020-11-24 US disclosed
US-10844038-B2 1,2-dithiolane compounds useful in neuroprotection, autoimmune and cancer diseases and conditions SABILA BIOSCIENCES LLC (US) 2020-11-24 US disclosed
US-10436798-B2 Means and methods for diagnosing and monitoring heart failure in a subject METANOMICS GMBH (DE) 2019-10-08 US disclosed
US-20190254955-A1 COVALENT TREATMENT WITH THIOLS OF KERATIN-CONTAINING MATERIALS LIVING PROOF, INC. 2019-08-22 US disclosed
EP-3527990-A1 USE OF SM_SPHINGOMYELIN (D18:1, C23:1) AS A MARKER FOR HEART FAILURE metanomics GmbH (DE) 2019-08-21 EP disclosed
EP-3190418-B1 USE OF SM_SPHINGOMYELIN (D18:1, C16:0) AS A MARKER FOR HEART FAILURE METANOMICS GMBH (DE) 2019-05-01 EP disclosed
WO-2018049127-A1 1,2-DITHIOLANE COMPOUNDS USEFUL IN NEUROPROTECTION, AUTOIMMUNE AND CANCER DISEASES AND CONDITIONS SABILA BIOSCIENCES LLC (US) 2018-03-15 WO disclosed
EP-3190418-A1 USE OF SM_SPHINGOMYELIN (D18:1, C16:0) AS A MARKER FOR HEART FAILURE metanomics GmbH (DE) 2017-07-12 EP disclosed
EP-2737321-B1 MEANS AND METHODS FOR DIAGNOSING AND MONITORING HEART FAILURE IN A SUBJECT METANOMICS GMBH (DE) 2017-03-01 EP disclosed
US-20150160238-A1 Means and Methods for Diagnosing and Monitoring Heart Failure in a Subject RUPRECHT-KARLS-UNIVERISTÄT HEIDELBERG (DE) 2015-06-11 US disclosed
EP-2737321-A2 MEANS AND METHODS FOR DIAGNOSING AND MONITORING HEART FAILURE IN A SUBJECT Metanomics GmbH (DE) 2014-06-04 EP disclosed
WO-2013014286-A2 MEANS AND METHODS FOR DIAGNOSING AND MONITORING HEART FAILURE IN A SUBJECT METANOMICS GMBH (DE) 2013-01-31 WO disclosed